Xtl Biopharmaceuticals XTLB
NASDAQ XTLB
$1.96 0.00 (-0.01%)
As of: Oct 19, 2026 · 12:25 PM EDT

Xtl Biopharmaceuticals (XTLB) Net Margin (2011 - 2024)

Updated

Xtl Biopharmaceuticals' Net Margin was -88.24% in the quarter ended Dec 31, 2024.

Analysis

Xtl Biopharmaceuticals (XTLB) Net Margin (2011 - 2024) Analysis & Trends

For the year ended Dec 31, 2024, Net Margin at Xtl Biopharmaceuticals came in at -227.72%.

  • The figure for the quarter ended Dec 31, 2024 marks the highest quarterly Net Margin since the quarter ended Mar 31, 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,147.31 Bn 1,115.89 Bn 19.71 Bn 30.88%
2 Johnson & Johnson 624.29 Bn 542.81 Bn 17.26 Bn 21.86%
3 AbbVie 511.65 Bn 484.76 Bn 12.70 Bn 21.27%
4 Merck 365.71 Bn 320.09 Bn 12.21 Bn -8.04%
5 Novartis Ag 297.61 Bn 261.60 Bn 11.24 Bn 22.65%
6 Astrazeneca 261.35 Bn 235.03 Bn 12.86 Bn 16.30%
7 Amgen 234.89 Bn 190.29 Bn 7.24 Bn 23.62%
8 Gilead Sciences 194.41 Bn 168.60 Bn 6.22 Bn -134.51%
9 Pfizer 172.08 Bn 118.73 Bn 10.94 Bn -1.65%
10 Xtl Biopharmaceuticals 18.55 Mn 15.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -88.24%
Sep 30, 2024 -262.09%
Mar 31, 2024 -26.52%
Mar 31, 2022 9.54%
Dec 31, 2021 87.99%
Mar 31, 2021 55.21%
Mar 31, 2020 40.23%
Mar 31, 2019 95.11%
Dec 31, 2018 285.20%
Sep 30, 2018 100.00%
Jun 30, 2018 100.00%
Mar 31, 2018 100.00%
Dec 31, 2017 -100.00%
Jun 30, 2017 -100.00%
Mar 31, 2017 -100.00%
Sep 30, 2016 -2,042.86%
Mar 31, 2016 -2,308.00%
Dec 31, 2015 -1,065.32%
Jun 30, 2015 -790.74%
Sep 30, 2014 -197.91%
API Access

Xtl Biopharmaceuticals Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=XTLB&period=max&api_key=YOUR_API_KEY